Allergic Rhinitis and Rhino-Conjunctivitis
Research activity is centered on grass pollen allergy with clinical interest in allergic rhino-conjunctivitis, including seasonal nasal and ocular symptoms affecting adolescents and adults.
- Grass pollen sensitization
- Allergic rhinoconjunctival disease
- Seasonal allergy management
The sponsor’s clinical focus includes the evaluation of allergen immunotherapy approaches for upper-airway allergic disease.
Allergic Asthma
The trial portfolio also includes allergic asthma, reflecting interest in patients whose respiratory allergy extends beyond nasal symptoms to lower-airway involvement.
- Asthma associated with pollen allergy
- Respiratory allergy
- Airway hypersensitivity
Clinical investigation is directed toward allergy-related respiratory disease within a combined upper- and lower-airway therapeutic setting.
Intralymphatic Allergen Immunotherapy
Research interest extends to intralymphatic allergen immunotherapy for pollen-induced allergy, with emphasis on treatment of allergic rhino-conjunctivitis using commercially available allergen extracts.
- Allergen immunotherapy
- Intralymphatic administration
- Commercial allergen extracts
This area reflects a therapeutic interest in targeted immune treatment for aeroallergen-driven disease.
Hymenoptera Venom Allergy
The broader allergic disease profile also includes allergy to Hymenoptera venoms, indicating interest in venom-related hypersensitivity conditions alongside inhalant allergy.
- Venom allergy
- Hymenoptera hypersensitivity
- Systemic allergic reactions
This supports a clinical interest in distinct forms of allergic disease requiring specialized immunologic care.
